May/June 2022 - Volume 45 - Issue 3 - Contributor Index

Alphabetical Search
B
O
Q
W
X

Effectiveness and Safety of Early High-Efficacy Versus Escalation Therapy in Relapsing-Remitting Multiple Sclerosis in Argentina

Rojas, Juan Ignacio; Patrucco, Liliana; Alonso, Ricardo; More

Clinical Neuropharmacology. 45(3):45-51, May/June 2022.

Effectiveness and Safety of Early High-Efficacy Versus Escalation Therapy in Relapsing-Remitting Multiple Sclerosis in Argentina

Rojas, Juan Ignacio; Patrucco, Liliana; Alonso, Ricardo; More

Clinical Neuropharmacology. 45(3):45-51, May/June 2022.

Effectiveness and Safety of Early High-Efficacy Versus Escalation Therapy in Relapsing-Remitting Multiple Sclerosis in Argentina

Rojas, Juan Ignacio; Patrucco, Liliana; Alonso, Ricardo; More

Clinical Neuropharmacology. 45(3):45-51, May/June 2022.

Effectiveness and Safety of Early High-Efficacy Versus Escalation Therapy in Relapsing-Remitting Multiple Sclerosis in Argentina

Rojas, Juan Ignacio; Patrucco, Liliana; Alonso, Ricardo; More

Clinical Neuropharmacology. 45(3):45-51, May/June 2022.

Author:
Deri, Norma MD

Effectiveness and Safety of Early High-Efficacy Versus Escalation Therapy in Relapsing-Remitting Multiple Sclerosis in Argentina

Rojas, Juan Ignacio; Patrucco, Liliana; Alonso, Ricardo; More

Clinical Neuropharmacology. 45(3):45-51, May/June 2022.

Author:
Endo, Hiroki BS

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Effectiveness and Safety of Early High-Efficacy Versus Escalation Therapy in Relapsing-Remitting Multiple Sclerosis in Argentina

Rojas, Juan Ignacio; Patrucco, Liliana; Alonso, Ricardo; More

Clinical Neuropharmacology. 45(3):45-51, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Effectiveness and Safety of Early High-Efficacy Versus Escalation Therapy in Relapsing-Remitting Multiple Sclerosis in Argentina

Rojas, Juan Ignacio; Patrucco, Liliana; Alonso, Ricardo; More

Clinical Neuropharmacology. 45(3):45-51, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Effectiveness and Safety of Early High-Efficacy Versus Escalation Therapy in Relapsing-Remitting Multiple Sclerosis in Argentina

Rojas, Juan Ignacio; Patrucco, Liliana; Alonso, Ricardo; More

Clinical Neuropharmacology. 45(3):45-51, May/June 2022.

Effectiveness and Safety of Early High-Efficacy Versus Escalation Therapy in Relapsing-Remitting Multiple Sclerosis in Argentina

Rojas, Juan Ignacio; Patrucco, Liliana; Alonso, Ricardo; More

Clinical Neuropharmacology. 45(3):45-51, May/June 2022.

Effectiveness and Safety of Early High-Efficacy Versus Escalation Therapy in Relapsing-Remitting Multiple Sclerosis in Argentina

Rojas, Juan Ignacio; Patrucco, Liliana; Alonso, Ricardo; More

Clinical Neuropharmacology. 45(3):45-51, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Shigetsura, Yuki; Imai, Satoshi; Endo, Hiroki; More

Clinical Neuropharmacology. 45(3):52-60, May/June 2022.

Author:
Zhou, Ting MD
Author:
Zhu, Hui MD
Show: